AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 129 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $2,385,000 | -14.0% | 69,244 | -58.3% | 0.00% | 0.0% |
Q2 2020 | $2,773,000 | -52.5% | 165,999 | -59.0% | 0.00% | -60.0% |
Q1 2020 | $5,839,000 | -47.5% | 404,967 | +21.9% | 0.01% | -28.6% |
Q4 2019 | $11,115,000 | +172.4% | 332,180 | +70.4% | 0.01% | +133.3% |
Q3 2019 | $4,080,000 | -8.8% | 194,956 | -9.3% | 0.00% | 0.0% |
Q2 2019 | $4,474,000 | +32.4% | 215,024 | +42.1% | 0.00% | +50.0% |
Q1 2019 | $3,379,000 | +48.1% | 151,270 | +58.6% | 0.00% | 0.0% |
Q4 2018 | $2,281,000 | -83.9% | 95,375 | -81.6% | 0.00% | -50.0% |
Q3 2018 | $14,137,000 | +12.8% | 518,288 | +11.2% | 0.00% | 0.0% |
Q2 2018 | $12,528,000 | +25.7% | 465,928 | +48.7% | 0.00% | -20.0% |
Q1 2018 | $9,968,000 | +19.9% | 313,269 | +42.5% | 0.01% | 0.0% |
Q4 2017 | $8,311,000 | +47.2% | 219,817 | -3.5% | 0.01% | +25.0% |
Q3 2017 | $5,647,000 | +141.7% | 227,880 | +100.4% | 0.00% | +100.0% |
Q2 2017 | $2,336,000 | +39.4% | 113,694 | +47.2% | 0.00% | +100.0% |
Q1 2017 | $1,676,000 | -21.4% | 77,222 | -25.9% | 0.00% | -50.0% |
Q4 2016 | $2,131,000 | +73.7% | 104,283 | +27.3% | 0.00% | +100.0% |
Q3 2016 | $1,227,000 | +51.7% | 81,937 | +9.4% | 0.00% | 0.0% |
Q2 2016 | $809,000 | +937.2% | 74,895 | +1193.5% | 0.00% | – |
Q1 2016 | $78,000 | +56.0% | 5,790 | +108.7% | 0.00% | – |
Q4 2015 | $50,000 | -35.1% | 2,774 | -9.8% | 0.00% | – |
Q3 2015 | $77,000 | – | 3,074 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |